J-TEC, in which Fujifilm had a 41 % stake since 2010, produces various regenerative medicine products such as myoblast sheets and regenerated liver tissue, with proprietary scaffolding methods. J-TEC has also developed a recombinant collagen produced in microorganisms which has excellent biocompatibility.

Fujifilm news release, Oct. 30, 2014